Health Products

Ranbaxy Metformin Product Recall (2020-02-26)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

RAN-Metformin 850 mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
AJY8006A, AJY8007A, AJY8005A, AJY8005B, AJY8008A
Recalling Firm
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
B. RAN-Metformin 500 mg TabletDIN 02269031TabletMeformin hydrochloride 500 mg
AJZ8005A
Recalling Firm
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
RAN-Metformin 850 mg TabletDIN 02269058TabletMeformin hydrochloride 850 mg

Introduction

  1. RAN-Metformin 850 mg Tablet
  2. RAN-Metformin 500 mg Tablet

Reason

Presence of N-nitrosodimethylamine (NDMA) above or near the interim acceptable concentration limit in affected lot(s).

Depth of distribution

Wholesalers, Healthcare Establishments, Retailers

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime